Skip to main content
. 2020 Jun 19;41(14):3922–3937. doi: 10.1002/hbm.25095

TABLE 3.

Summary demographic information for cases and controls in the five analysed samples with white matter integrity measures (FA and MD)

Sample Characteristic Controls Cases
Current depression cMDD‐STR Size 40 40
Sex (male/female) 10/30 10/30
Age (years) 55.03 (9.77) 54.23 (10.35)
QIDS 3.58 (2.54) 14.13 (3.88)
Medicated 2 28
cMDD‐UKB Size 1,435 1,435
Sex (male/female) 451/984 451/984
Age (years) 60.11 (7.16) 60.11 (7.16)
Past depression rMDD‐STR Size 202 202
Sex (male/female) 56/146 56/146
Age (years) 57.89 (8.84) 56.97 (9.28)
QIDS 3.53 (2.36) 5.38 (3.68)
pMDD‐UKB‐CIDI Size 3,418 3,418
Sex (male/female) 1,094/2,324 1,094/2,324
Age (years) 61.46 (7.09) 61.44 (7.11)
pMDD‐UKB‐ICD Size 289 289
Sex (male/female) 97/192 97/192
Age (years) 61.77 (7.70) 61.76 (7.70)

Note: Standard deviations for age and QIDS are in brackets. In cMDD‐STR sample participants were considered medicated if they had at least one antidepressant prescription.

Abbreviations: cMDD‐STR, current MDD criteria in STRADL cohort; cMDD‐UKB, probable current MDD criteria in UK Biobank cohort; pMDD‐UKB‐CIDI, lifetime MDD criteria based on the online Composite International Diagnostic Interview (CIDI) in UK Biobank cohort; pMDD‐UKB‐ICD, lifetime MDD criteria based on ICD and hospital records in UK Biobank cohort; QIDS, Quick Inventory of Depressive Symptomatology; rMDD‐STR, remitted MDD criteria in STRADL cohort.